BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2447179)

  • 1. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
    Nakagawa T; Nakagawa N; Ambrus JL; Fauci AS
    J Immunol; 1988 Jan; 140(2):465-9. PubMed ID: 2447179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus.
    Ueda Y; Sakane T; Tsunematsu T
    J Immunol; 1989 Dec; 143(12):3988-93. PubMed ID: 2592765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor.
    Ambrus JL; Chesky L; Stephany D; McFarland P; Mostowski H; Fauci AS
    J Immunol; 1990 Dec; 145(12):3949-55. PubMed ID: 2258603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.
    Nakagawa T; Nakagawa N; Goldstein H; Volkman DJ; Fauci AS
    J Immunol; 1986 Nov; 137(10):3175-82. PubMed ID: 2945860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential synergistic effect of interleukin 2 and interferon-gamma on the differentiation of a Tac-antigen-positive B cell line.
    Nakagawa T; Nakagawa N; Volkman DJ; Fauci AS
    J Immunol; 1986 Jan; 136(1):164-8. PubMed ID: 2999242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and the functional role of a p70/75 interleukin 2-binding molecule in human B cell.
    Saiki O; Tanaka T; Doi S; Kishimoto S
    J Immunol; 1988 Feb; 140(3):853-8. PubMed ID: 2828472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
    J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory influence of IL-4 on human B cell responsiveness.
    Jelinek DF; Lipsky PE
    J Immunol; 1988 Jul; 141(1):164-73. PubMed ID: 2837507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.
    Thompson CB; Schaefer ME; Finkelman FD; Scher I; Farrar J; Mond JJ
    J Immunol; 1985 Jan; 134(1):369-74. PubMed ID: 3917279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
    Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P
    J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
    J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH; Muraguchi A; Fauci AS
    Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
    Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
    Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.